Bromodomain and Extra-terminal (BET) Bromodomain Inhibition Activate Transcription via Transient Release of Positive Transcription Elongation Factor b (P-TEFb) from 7SK Small Nuclear Ribonucleoprotein*

Background: P-TEFb regulates transcription elongation, cell growth, and proliferation. Results: BET bromodomain inhibition by JQ1 transiently releases free P-TEFb from the inactive 7SK snRNP, thus activating HEXIM1 and HIV transcription. Conclusion: JQ1 affects the P-TEFb equilibrium. Significance: P-TEFb release from and reassembly into 7SK snRNP by JQ1 inhibits tumor cell growth and reactivates latent HIV. By phosphorylating elongation factors and the C-terminal domain of RNA polymerase II, the positive transcription elongation factor b (P-TEFb) is the critical kinase for transcription elongation and co-transcriptional processing of eukaryotic genes. It exists in inactive small nuclear ribonucleoprotein (7SK snRNP) and active (free P-TEFb) complexes in cells. The P-TEFb equilibrium determines the state of cellular activation, proliferation, and differentiation. Free P-TEFb, which is required for growth, can be recruited to RNA polymerase II via transcription factors, BRD4, or the super elongation complex (SEC). UV light, various signaling cascades, transcriptional blockade, or compounds such as hexamethylene bisacetamide (HMBA), suberoylanilide hydroxamic acid (SAHA), and other histone deacetylase inhibitors lead to a rapid release of free P-TEFb, followed by its reassembly into the 7SK snRNP. As a consequence, transcription of HEXIM1, a critical 7SK snRNP subunit, and HIV is induced. In this study, we found that a bromodomain and extra-terminal (BET) bromodomain inhibitor, JQ1, which inhibits BRD4 by blocking its association with chromatin, also leads to the rapid release of free P-TEFb from the 7SK snRNP. Indeed, JQ1 transiently increased levels of free P-TEFb and BRD4·P-TEFb and SEC·P-TEFb complexes in cells. As a consequence, the levels of HEXIM1 and HIV proteins rose. Importantly, the knockdown of ELL2, a subunit of the SEC, blocked the ability of JQ1 to increase HIV transcription. Finally, the effects of JQ1 and HMBA or SAHA on the P-TEFb equilibrium were cooperative. We conclude that HMBA, SAHA, and JQ1 affect transcription elongation by a similar and convergent mechanism.

[1]  P. Sebastiani,et al.  BET bromodomain inhibition as a novel strategy for reactivation of HIV‐1 , 2012, Journal of leukocyte biology.

[2]  M. Dawson,et al.  Cancer Epigenetics: From Mechanism to Therapy , 2012, Cell.

[3]  J. Peiris,et al.  Editorial: Macrophage heterogeneity and responses to influenza virus infection , 2012, Journal of leukocyte biology.

[4]  M. Geyer,et al.  Serine-7 but not serine-5 phosphorylation primes RNA polymerase II CTD for P-TEFb recognition , 2012, Nature Communications.

[5]  A. Shilatifard,et al.  The Super Elongation Complex Family of RNA Polymerase II Elongation Factors: Gene Target Specificity and Transcriptional Output , 2012, Molecular and Cellular Biology.

[6]  Qiang Zhou,et al.  RNA polymerase II elongation control. , 2012, Annual review of biochemistry.

[7]  B. Peterlin,et al.  7SK snRNA: a noncoding RNA that plays a major role in regulating eukaryotic transcription , 2012, Wiley interdisciplinary reviews. RNA.

[8]  Andrew P. Rice,et al.  Regulation of Cyclin T1 and HIV-1 Replication by MicroRNAs in Resting CD4+ T Lymphocytes , 2011, Journal of Virology.

[9]  E. Verdin,et al.  Two-pronged Binding with Bromodomain-containing Protein 4 Liberates Positive Transcription Elongation Factor b from Inactive Ribonucleoprotein Complexes* , 2011, The Journal of Biological Chemistry.

[10]  P. Sandy,et al.  Targeting MYC dependence in cancer by inhibiting BET bromodomains , 2011, Proceedings of the National Academy of Sciences.

[11]  X. Lu,et al.  Signal-induced Brd4 release from chromatin is essential for its role transition from chromatin targeting to transcriptional regulation , 2011, Nucleic acids research.

[12]  R. Young,et al.  BET Bromodomain Inhibition as a Therapeutic Strategy to Target c-Myc , 2011, Cell.

[13]  Tetsuya Nakamura,et al.  Gene bookmarking accelerates the kinetics of post-mitotic transcriptional re-activation , 2011, Nature Cell Biology.

[14]  A. Shilatifard,et al.  Human Mediator Subunit MED26 Functions as a Docking Site for Transcription Elongation Factors , 2011, Cell.

[15]  D. Gilmour,et al.  Promoter proximal pausing and the control of gene expression. , 2011, Current opinion in genetics & development.

[16]  A. Shilatifard,et al.  The super elongation complex (SEC) and MLL in development and disease. , 2011, Genes & development.

[17]  S. Nechaev,et al.  Pol II waiting in the starting gates: Regulating the transition from transcription initiation into productive elongation. , 2011, Biochimica et biophysica acta.

[18]  C. Rice,et al.  Suppression of inflammation by a synthetic histone mimic , 2010, Nature.

[19]  William B. Smith,et al.  Selective inhibition of BET bromodomains , 2010, Nature.

[20]  D. Price,et al.  The Mechanism of Release of P-TEFb and HEXIM1 from the 7SK snRNP by Viral and Cellular Activators Includes a Conformational Change in 7SK , 2010, PloS one.

[21]  A. Burlingame,et al.  HIV-1 Tat and host AFF4 recruit two transcription elongation factors into a bifunctional complex for coordinated activation of HIV-1 transcription. , 2010, Molecular cell.

[22]  C. Bach,et al.  Misguided Transcriptional Elongation Causes Mixed Lineage Leukemia , 2009, PLoS biology.

[23]  C. Milcarek,et al.  Transcription elongation factor ELL2 directs immunoglobulin secretion in plasma cells by stimulating altered RNA processing , 2009, Nature Immunology.

[24]  R. Medzhitov,et al.  Control of Inducible Gene Expression by Signal-Dependent Transcriptional Elongation , 2009, Cell.

[25]  J. McCune,et al.  Suberoylanilide Hydroxamic Acid Reactivates HIV from Latently Infected Cells* , 2009, Journal of Biological Chemistry.

[26]  A. Rice,et al.  miR-198 Inhibits HIV-1 Gene Expression and Replication in Monocytes and Its Mechanism of Action Appears To Involve Repression of Cyclin T1 , 2009, PLoS pathogens.

[27]  Tina Lenasi,et al.  Transcriptional interference antagonizes proviral gene expression to promote HIV latency. , 2008, Cell host & microbe.

[28]  Qiang Zhou,et al.  PP2B and PP1alpha cooperatively disrupt 7SK snRNP to release P-TEFb for transcription in response to Ca2+ signaling. , 2008, Genes & development.

[29]  Tina Lenasi,et al.  HMBA Releases P-TEFb from HEXIM1 and 7SK snRNA via PI3K/Akt and Activates HIV Transcription , 2007, PLoS pathogens.

[30]  O. Bensaude,et al.  Retrovirology BioMed Central , 2006 .

[31]  D. Price,et al.  Manipulation of P-TEFb control machinery by HIV: recruitment of P-TEFb from the large form by Tat and binding of HEXIM1 to TAR , 2007, Nucleic acids research.

[32]  Qiang Zhou,et al.  Tat competes with HEXIM1 to increase the active pool of P-TEFb for HIV-1 transcription , 2007, Nucleic acids research.

[33]  Qiang Zhou,et al.  Modulation of a P-TEFb Functional Equilibrium for the Global Control of Cell Growth and Differentiation , 2006, Molecular and Cellular Biology.

[34]  B. Peterlin,et al.  Controlling the elongation phase of transcription with P-TEFb. , 2006, Molecular cell.

[35]  John T. Lis,et al.  Breaking barriers to transcription elongation , 2006, Nature Reviews Molecular Cell Biology.

[36]  K. Bomsztyk,et al.  Protocol for the fast chromatin immunoprecipitation (ChIP) method , 2006, Nature Protocols.

[37]  M. Montano,et al.  The breast cell growth inhibitor, estrogen down regulated gene 1, modulates a novel functional interaction between estrogen receptor alpha and transcriptional elongation factor cyclin T1 , 2005, Oncogene.

[38]  J. Brady,et al.  The bromodomain protein Brd4 is a positive regulatory component of P-TEFb and stimulates RNA polymerase II-dependent transcription. , 2005, Molecular cell.

[39]  Qiang Zhou,et al.  Recruitment of P-TEFb for stimulation of transcriptional elongation by the bromodomain protein Brd4. , 2005, Molecular cell.

[40]  B. Wittmann,et al.  Identification of a novel inhibitor of breast cell growth that is down-regulated by estrogens and decreased in breast tumors. , 2003, Cancer research.

[41]  A. Rabson,et al.  NF-κ B-Dependent and -Independent Pathways of HIV Activation in a Chronically Infected T Cell Line , 1994 .